Oral pentoxifylline and topical clobetasol propionate ointment in the treatment of pretibial myxoedema, with concomitant improvement of Graves' ophthalmopathy [24]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 10, 2007, Pages 1441-1443

  Pineda, A M M ^a   Tianco, E A V ^a   Tan, J B ^a   Casintahan, F A ^a   Beloso, M B ^a  

^a Jose R Reyes Memorial Medical Center   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; MUCIN; PENTOXIFYLLINE;

ADULT; CASE REPORT; DERMIS; DRUG RESPONSE; ENDOCRINE OPHTHALMOPATHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MYXEDEMA; PRIORITY JOURNAL; SKIN BIOPSY;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; CLOBETASOL; FEMALE; GRAVES DISEASE; HUMANS; MIDDLE AGED; MYXEDEMA; OINTMENTS; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; TIBIA;

EID: 35648996997     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02259.x     Document Type: Letter

References (9)

1. Jabbour SA. Cutaneous manifestations of endocrine disorders: A guide for dermatologists. Am J Clin Dermatol 2003; 4: 15-31.
2. Fatourechi V, Ahmed DD, Schwartz KM. Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab 2002; 87: 5435-5441.
3. Georgala S, Katoulis AC, Georgala C, Katoulis EC, Hatziolou E, Stavrianeas NG. Pretibial myxedema as the initial manifestation of Graves' disease. J Eur Acad Dermatol Venereol 2002; 16: 380-383.
4. Kriss JP. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 1987; 16: 9-15.
5. Chang CC, Chang TC, Kao SC, Kuo YF, Chien LF. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxedema. Acta Endocrinol (Copenh) 1993; 129: 322-327.
6. Chang TC, Kao SC, Huang KM. Octreotide and Graves' ophthalmopathy and pretibial myxedema. BMJ 1992; 304: 158.
7. Finamor FE, Martins JR, Nakanami D, Paiva ER, Manso PG, Furlanetto RP. Pentoxifylline (PTX) - an alternative treatment in Graves' ophthalmopathy (inactive phase): Assessment by a disease specific quality of life questionnaire and by exophthalmometry in a prospective randomized trial. Eur J Ophthalmol 2004; 14: 277-283.
8. Lang P, Sisson J, Lynch P. Intralesional triamcinolone therapy for pretibial myxedema. Arch Dermatol 1975;111: 197-202.
9. Schwartz KM, Fatourechi V, Ahmed DD, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): Long-term outcome. J Clin Endocrinol Metab 2002; 87: 438-446.